Venous thromboembolism in obstetrics and gynecology

Obstetrics and Gynecology

Volumn 109, Issue 3, 2007, Pages 761-777

  Krivak, Thomas C ^a   Zorn, Kristin K ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; D DIMER; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTINUOUS INFUSION; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; DIAGNOSTIC TEST; DOPPLER ECHOGRAPHY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; ECHOCARDIOGRAPHY; FIBRINOLYTIC THERAPY; GYNECOLOGICAL EXAMINATION; GYNECOLOGY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LABORATORY TEST; LOADING DRUG DOSE; LONG TERM CARE; MOBILIZATION; OBSTETRIC CARE; OBSTETRIC PATIENT; OBSTETRICS; OSTEOPOROSIS; OUTCOME ASSESSMENT; PNEUMATIC TOOL; POSTOPERATIVE COMPLICATION; PREGNANCY; PRIORITY JOURNAL; PROTECTIVE CLOTHING; RISK FACTOR; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; THROMBECTOMY; THROMBOSIS PREVENTION; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT PLANNING; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

ALGORITHMS; ANTICOAGULANTS; BLOOD COAGULATION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; THROMBOPHILIA; VENA CAVA FILTERS; VENOUS THROMBOSIS; VENTILATION-PERFUSION RATIO;

EID: 33847363078     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000255819.10187.70     Document Type: Article

References (121)

1. American College of Obstetricians and Gynecologists. Prevention of deep vein thrombosis and pulmonary embolism. ACOG Practice Bulletin 21. Washington, DC: ACOG; 2000.
2. Gherman RB, Goodwin TM, Leung B, Bryne JD, Hethumumi R, Montoro M. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol 1999;94:730-4.
3. Bonnar J. Can more be done in obstetrics and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism? Am J Obstet Gynecol 1999;180:784-91.
4. Carr MH, Towers CV, Eastenson AR, Pircon RA, Iriye BK, Adashek JA. Prolonged bedrest during pregnancy: does the risk of deep vein thrombosis warrant the use of routine heparin prophylaxis. J Matern Fetal Med 1997;6:264-7.
5. Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillany M, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000;342:374-80.
6. Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005;106:517-24.
7. Ginsberg JS, Chan WS, Bates SM, Kaatz S. Anticoagulation of pregnant women with mechanical heart valves. Arch Intern Med 2003;163:694-8.
8. Toglia MR, Weg JG. Venous thromboembolism during pregnancy. N Engl J Med 1996;335:108-14.
9. Goodacre S, Sutton AJ, Sampson FC. Meta-analysis: the value of clinical assessment in the diagnosis of deep venous thrombosis. Ann Intern Med 2005;143:129-39.
10. Myers ER, Clarke-Pearson DL, Olt GJ, Soper JT, Berchuck A. Preoperative coagulation testing on a gynecologic oncology service. Obstet Gynecol 1994;83:438-44.
11. Olt GJ, Greenberg C, Synan I, Coleman RE, Clarke-Pearson D. Preoperative assessment of fragment D-dimer as a predictor of postoperative venous thrombosis. Am J Obstet Gynecol 1990;162:772-5.
12. Anderson AA, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003;107:I9-I16.
13. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon M, Melton J. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000;160:809-15.
14. Tutschek B, Struve S, Goecke T, Pilliny M, Zotz R, Gerhardt A, et al. Clinical risk factors for deep vein thrombosis in pregnancy and the puerperium. J Perinat Med 2002;30:367-70.
15. Cook D, Crowther M, Meade M, Rabbat C, Griffith L, Schiff D, et al. Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors. Crit Care Med 2005;33:1565-71.
16. Danilenko-Dixon DR, Heit JA, Silverstein MD, Yawn BP, Petterson TM, Lohse CM, et al. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or postpartum: a population-based case control study. Am J Obstet Gynecol 2001;184:104-10.
17. Simpson EL, Lawrenson RA, Nightingale AL Farmer RDT. Venous thromboembolism in pregnancy and puerperium: incidence and additional factors from a London peritoneal database. BJOG 2001;108:56-60.
18. Lindqvist P, Dahlback BD, Marsal K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol 1999;94:595-9.
19. Stein PD, Hull RD, Kayali F, Olson RE, Alshab AK, Meyers FA, et al. Venous thromboembolism in pregnancy: 21 year trends. Am J Med 2004;164:2260-5.
20. Chisaka H, Utsunomiya H, Okamura K, Yaegashi N. Pulmonary embolism following gynecologic surgery and cesarean section. Int J Gynaecol Obstet 2004;84:47-53.
21. Davis JD. Prevention, diagnosis and treatment of venous thromboembolism of gynecologic surgery. Am J Obstet Gynecol 2001;184:759-75.
22. Abu-Rustum NR, Richard S, Wilton A, Lev G, Sonoda Y, Hensley ML, et al. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival. Gynecol Oncol 2005;99:320-6.
23. Wasowicz-Kemps DK, Biesma DH, Van Leeuwen S, Ramshorst RV. Prophylaxis of venous thromboembolism in general gynecologic day surgery in the Netherlands. J Thromb Haemost 2006;4:269-71.
24. Taberner DA, Poller L, Burslem RW, Jones JB. Oral anticoagulants by the British comparative thromboplastin versus low-dose heparin in prophylaxis of deep vein thrombosis. Br Med J 1978;1:272-4.
25. Bergqvist D. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery. Br J Surg 2004;91:965-74.
26. Cyrkowicz A. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of low molecular weight heparin: gynecological ward retrospective analysis. Eur J Obstet Gynecol Reprod Biol 2002;100:223-6.
27. Clarke-Pearson DL, Synan IS, Dodge R, Soper JT, Berchuck A, Coleman RE. A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery. Am J Obstet Gynecol 1993;168:1146-54.
28. Lepercq J, Conrad J, Borel-Derlon A, Darmon JY, Boudignat O, Francoual C, et al. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. BJOG 2001;108:1134-40.
29. Turner GM, Cole SE, Brooks JH. The efficacy of graduated compression stockings in the prevention of deep vein thrombosis after major gynaecologic surgery. Br J Obstet Gynaecol 1984;91:588-91.
30. Bergqvist D. Assessment of the risk and the prophylaxis of venous thromboembolism in surgical patients. Pathophysiol Haemost Thromb 2004;33:358-61.
31. Schulz SL, Stechemesser B, Seeberger U, Meyer D, Kesselring C. Graduated compression stockings for the prevention of venous thromboembolism in surgical patients in the age of low molecular weight heparin. J Thromb Haemost 2005;3:2363-5.
32. Clarke-Pearson DL, Dodge RK, Synan I, McClelland RC, Maxwell GL. Venous thromboembolism prophylaxis: patients at high risk to fail intermittent pneumatic compression. Obstet Gynecol 2003;101:157-63.
33. National Institutes of Health Consensus Development conference. Prevention of venous thromboembolism and pulmonary embolism. JAMA 1986;255:744-9.
34. American College of Obstetricians and Gynecologists. Thromboembolism in pregnancy. ACOG Practice Bulletin 19. Washington, DC:ACOG; 2000.
35. Sarani B, Chun A, Venbrux A. Role of optional (retrievable) IVC filters in surgical patients at risk for venous thromboembolic disease. J Am Coll Surg 2005;201:957-64.
36. Athanasoulis CA, Kaufman JA, Halpern EF, Waltman AC, Geller SC, Fan CM. Inferior vena caval filters: review of a 26-year single-center clinical experience. Radiology 2000;216:54-66.
37. Rutherford RB. Prophylactic indications for vena cava filters: a critical appraisal. Semin Vasc Surg 2005;18:158-65.
38. Maxwell GL, Myers ER, Clarke-Pearson DL. Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery. Obstet Gynecol 2000;95:206-14.
39. Clarke-Pearson DL, Creasman WT, Coleman RE, Synan IS, Hinshaw WM. Perioperative external pneumatic calf compression as thromboembolism prophylaxis in gynecologic oncology: report of a randomized controlled trial. Gynecol Oncol 1984;18:226-32.
40. Clarke-Pearson DL, Synan IS, Hinshaw WM, Coleman RE, Creasman WT. Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy. Obstet Gynecol 1984;63:92-8.
41. Borstad E, Urdal K, Handeland G, Abildgaard U. Comparison of low molecular weight heparin vs unfractionated heparin in gynecologic surgery. Acta Obstet Gynecol Scand 1988;67:99-103.
42. Kakkar VV, Cohen AT, Edmonson RA, Phillips MJ, Cooper DJ, Das SK, et al. Low molecular weight versus standard heparin for the prevention of venous thromboembolism after major abdominal surgery. Lancet 1993;341:259-65.
43. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med 1988;318:1162-73.
44. Ballard RM, Bradley-Watson PJ, Johnstone FD, Kenney A, McCarthy TG. Low doses of subcutaneous heparin in the prevention of deep vein thrombosis after gynaecologic surgery. J Obstet Gynaecol Br Commonw 1973;80:469-72.
45. Borstad E, Urdal K, Handeland G, Abildgaard U. Comparison of low molecular weight heparin vs unfractionated heparin in gynecologic surgery II: reduced dose of low molecular weight heparin. Acta Obstet Gynecol Scand 1992;71:471-5.
46. Clarke-Pearson DL, Coleman RE, Synan IS, Hinshaw W, Creasman WT. Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin. Am J Obstet Gynecol 1983;145:606-13.
47. Clarke-Pearson DL, DeLong E, Synan IS, Soper JT, Creasman WT, Coleman RE. A controlled trial of two low-dose heparin regimens for the prevention of postoperative deep vein thrombosis. Obstet Gynecol 1990;75:684-9.
48. Clarke-Pearson DL, DeLong ER, Synan IS, Creasman WT. Complications of low-dose heparin prophylaxis in gynecologic oncology surgery. Obstet Gynecol 1984;64:689-93.
49. Maxwell GL, Synan I, Dodge R, Carroll B, Clarke-Pearson DL. Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial. Obstet Gynecol 2001;98:989-95.
50. Maxwell GL, Synan I, Hayes P, Clarke-Pearson DL. Preference and compliance in postoperative thromboembolism prophylaxis among gynecologic oncology patients. Obstet Gynecol 2002;100:451-5.
51. Lindhoff-Last E, Nakov R, Misselwitz F, Breddin HK, Bauersachs R. Incidence and clinical relevance of heparin-induced antibodies in patients with deep vein thrombosis treated with unfractionated or low-molecular-weight heparin. Br J Haemotol 2002;118:1137-42.
52. Dahlman TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993;168:1265-70.
53. Geerts WH, Pineo GF, Heit JA, Bergqvist D Lassen MR, Colwell CW et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Antithrombolytic Therapy. Chest 2004;126:338S-400S.
54. Dainty L, Maxwell GI, Clarke-Pearson DL, Meyers ER. Cost-effectiveness of combination thromboembolism prophylaxis in gynecologic oncology surgery. Gynecol Oncol 2004;93:366-73.
55. Wille-Jorgensen P, Rasmussen MS, Andersen BR, Borly L. Heparins and mechanical methods for thromboprophylaxis in colorectal surgery (Cochrane Review). In: The Cochrane Library, Issue 3, 2006. Oxford: Update Software.
56. Clarke-Pearson DL, Synan IS, Coleman RE, Hinshaw W, Creasman WT. The natural history of postoperative venous thromboemboli in gynecologic oncology: a prospective study of 382 patients. Am J Obstet Gynecol 1984;148:1051-4.
57. Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis: a meta-analysis of randomized, controlled trials. Ann Intern Med 1999;130:800-9.
58. Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002;346:975-80.
59. Weiss N, Bernstein PS. Risk factor scoring for predicting venous thromboembolism in obstetric patients. Am J Obstet Gynecol 2000;182:1073-10.
60. Martinelli I, DeStefano V, Taioli E, Paciaroni K, Rossi E, Mannucci PM. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb Haemost 2002;87:791-95.
61. Adachi T, Hashiguchi K, Arai Y, Ohta H. Clinical study of venous thromboembolism during pregnancy and puerperium. Semin Thromb Hemost 2001;27:149-53.
62. Nelson-Piercy C, Letsky EA, de Swiet M. Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol 1997;176:1062-8.
63. Gates S, Brocklehurst P, Ayers S, Bowler U. Thromboprophylaxis and pregnancy: two randomized controlled pilot trials that used low-molecular-weight heparin. Am J Obstet Gynecol 2004;191:1296-1303.
64. Sephton V, Farquharson RG, Topping J, Quenby SM, Cowan C, Back DJ, et al. A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy. Obstet Gynecol 2003;101:1307-11.
65. Gallus AS. Management options for thrombophilias. Semin Thrombo Hemost 2005;31:118-26.
66. Brill-Edwards P, Ginsberg JS, Gent M, Hirsch J, Burrows R, Kearon C, et al. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. N Engl J Med 2000;343:1439-44.
67. Johnston JA, Brill-Edwards P, Ginsberg JS, Pauker SG, Eckman MH. Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism. Am J Med 2005;118:503-14.
68. Burrows RF, Gan ET, Gallus AS, Wallace EM, Burrows EA. A randomized double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study. BJOG 2001;108:835-9.
69. Jacobsen AF, Drolsum A, Klow NE, Dahl GF, Qvigstad E, Sandset PM. Deep vein thrombosis after elective cesarean section. Thromb Res 2004;113:283-8.
70. Quinones JN, James DN, Stamilio DM, Cleary KL, Macones GA. Thromboprophylaxis after cesarean delivery: a decision analysis. Obstet Gynecol 2005;106:733-40.
71. Lev-Ran O, Kramer A, Gurevitch J, Shapira I, Mohr R. Low-molecular-weight heparin for prosthetic heart valves: treatment failure. Ann Thorac Surg 2000;69:264-6.
72. Rowan JA, McCowan LM, Raudkivi PJ, North RA. Enoxaparin treatment in women with mechanical heart valves during pregnancy. Am J Obstet Gynecol 2001;185:633-7.
73. Safety of Lovenox in pregnancy. ACOG Committee Opinion No. 276. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;100:845-6.
74. De Santo LS, Romano G, Della Corte A, Tizzano F, Petraio A, Amarelli C, et al. Mitral mechanical replacement in young rheumatic women: analysis of long-term survival, valve-related complications, and pregnancy outcomes over a 3707-patient-year follow-up. J Thorac Cardiovasc Surg 2005;130:13-9.
75. Bates SM, Greer IA, Hirsch J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:627S-44S.
76. Stevenson RE, Burton OM, Ferlauto GJ, Taylor HA. Hazards of oral anticoagulants during pregnancy. JAMA 1980;243:1549-51.
77. Kearon C, Ginsberg JS, Douketis J, Crowther MA, Turpie AG, Bates SM, et al. A randomized trial of diagnostic strategies after proximal vein ultrasonography for suspected deep venous thrombosis: d-dimer testing compared with repeated ultrasonography. Ann Intern Med 2005;142:490-6.
78. Kearon C, Julian JA, Newman TE, Ginsberg JS. Noninvasive diagnosis of deep venous thrombosis. Ann Internal Med 1998;128:663-77.
79. Subramaniam RM, Chou T, Heath R, Allen R. Importance of pretest probability score and D-dimer assay before sonography for lower limb deep venous thrombosis. AJR Am J Roentgenol 2006;186:206-12.
80. Kearon C, Ginsberg JS, Douketis J, Turpie AG, Bates SM, Lee AY, et al. An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial. Ann Intern Med 2006;144:812-21.
81. Linkins LA, Bates SM, Ginsberg JS, Kearon C. Use of different D-dimer levels to exclude venous thromboembolism depending on clinical pretest probability. J Thromb Haemost 2004;2:1256-60.
82. Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J, et al. Evaluation of D-dimer in the diagnosis of suspected deep-venous thrombosis. N Engl J Med 2003;349:1227-35.
83. Ghirardini G, Battioni M, Bertellini C, Colombini R, Colla R, Rossi G. D-dimer after delivery in uncomplicated pregnancies. Clin Exp Obstet Gynecol 1999;26:211-2.
84. Huisman MV, Buller HR, Cate JW, Vreeken J. Serial impedance plethysmography for suspected deep venous thrombosis in outpatients: the Amsterdam General Practitioner Study. N Engl J Med 1986;314:823-8.
85. Stein PD, Hull RD, Pineo G. Strategy that includes serial noninvasive tests for diagnosis of thromboembolic disease in patients with suspected acute pulmonary embolism based on data from PIOPED. Arch Intern Med 1995;155:2101-4.
86. Martino MA, Borges E, Williamson E, Siegfried S, Cantor AB, Lancaster J, et al. Pulmonary embolism after major abdominal surgery in gynecologic oncology. Obstet Gynecol 2006;107:666-71.
87. Raskob GE, Hull RD. Diagnosis of pulmonary embolism. Curr Opin Hematol 1999;6:280-4.
88. Bates S. Treatment and prophylaxis of venous thromboembolism during pregnancy. Thromb Res 2002;108:97-106.
89. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386-9.
90. Nijkeuter M, Ginsberg JS, Huisman MV. Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy: a systematic review. J Thromb Haemost 2006;4:496-500.
91. The PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 1990;263:2753-9.
92. Roy PM, Colombet I, Durieux P, Chatellier G, Sors H, Meyer G. Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ 2005;331:25-9.
93. Chan WS, Ginsberg JS. Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy. Thromb Res 2002;107:85-91.
94. Worsley DF, Alavi A. Comprehensive analysis of the results of the PIOPED Study. J Nucl Med 1995;36:2380-7.
95. Stein PD, Hull RD, Pineo G. Strategy that includes serial noninvasive leg tests for diagnosis of thromboembolic disease in patients with suspected acute pulmonary embolism based on data from PIOPED. Arch Intern Med 1995;155:2101-4.
96. Balan KK, Critchley M, Vedavathy KK, Smith ML, Vinjamuri S. The value of ventilation-perfusion imaging in pregnancy. Br J Radiol 1997;70:338-40.
97. Chan WS, Ray JG, Murray S, Coady GE, Coates G, Ginsberg JS. Suspected pulmonary embolism in pregnancy: clinical presentation, results of lung scanning, and subsequent maternal and pediatric outcomes. Arch Intern Med 2002;162:1170-5.
98. Patel S, Kazerooni EA. Helical CT for the evaluation of acute pulmonary embolism. AJR Am J Roentgenol 2005;185:135-49.
99. Winer-Muram HT, Boone JM, Brown HL, Jennings SG, Mabie WC, Lombardo GT. Pulmonary embolism in pregnant patients: fetal radiation dose with helical CT. Radiology 2002;224:487-92.
100. Doyle NM, Ramirez MM, Mastrobattista JM, Monga M, Wagner LK, Gardner MO. Diagnosis of pulmonary embolism: a cost effective analysis. Am J Obstet Gynecol 2004;191:1019-23.
101. Stevens SM, Elliott CG, Chan KJ, Egger MJ, Ahmed KM. Withholding anticoagulation after a negative result on duplex ultrasonography for suspected deep venous thrombosis. Ann Intern Med 2004;140:985-91.
102. Hull RD, Raskob GE, Rosenbloom D, Panja AA, Brill-Edwards P, Ginsberg JS, et al. Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. N Engl J Med 1990;322:1260-4.
103. Bates SM, Ginsberg JS. Treatment of deep vein thrombosis. N Engl J Med 2004;351:268-77.
104. Cruickshank MK, Levine MN, Hirsh J, Roberts R, Siguenza M. A standard nomogram for the management of heparin therapy. Arch Intern Med 1991;151:333-7.
105. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a "standard care" nomogram. Ann Intern Med 1993;119:874-81.
106. Buller HR, Agnelli C, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:401S-28S.
107. Kirchmaier CM, Wolf H, Schafer H, Ehlers B, Breddin HK. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Int Angiol 1998;17:135-45.
108. Gould MK, Dembitzer AD, Sanders GD, Garber AM. Low-molecular-weight heparins compared with unfractionated heparin for the treatment of acute deep venous thrombosis: a cost-effectiveness analysis. Ann Intern Med 1999;130:789-99.
109. The Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997;337:657-62.
110. Mismetti P, Quenet S, Levine M, Merli G, Decousus H, Derobert E, et al. Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis. Chest 2005;128:2203-10.
111. Breddin HK, Hach-Wunderle V, Nakov R, Kakkar VV, et al; CORTES investigators. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis. N Engl J Med 2001;344:626-31.
112. Merli G, Spiro TE, Olsson CG, Abildgaard U, Davidson BL, Eldor A, et al. Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med 2001;134:191-202.
113. Simonneau G, Sors H, Charbonnier B, Page Y, Laaban JP, Azarian R, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997;337:663-9.
114. Levine M, Gent M, Hirsh J, Leclerc J, Anderson D, Weitz J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep vein thrombosis. N Engl J Med 1996;334:677-81.
115. Levine M, Hirsh J, Gent M, Turpie AG, Weitz J, Ginsberg J, et al. Optimal duration of oral anticoagulation therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 1995;74:606-11.
116. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999;340:901-7.
117. Schulman S, Granqvist S, Holmstrom M, Carlson A, Lindmarker P, Nicol P, et al. The duration of oral anticoagulation therapy after a second episode of venous thromboembolism. N Engl J Med 1997;336:393-8.
118. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Larfars G, Nicol P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995;332:1661-5.
119. McColl MD, Greer IA. Low-molecular-weight heparin for the prevention and treatment of venous thromboembolism in pregnancy. Curr Opin Pulm Med 2004;10:371-5.
120. Kawamata Z, Chiba Y, Tanaka R, Higashi M, Nishigami K. Experience of temporary inferior vena cava filters inserted in the perinatal period to prevent pulmonary embolism in pregnant women with deep vein thrombosis. J Vasc Surg 2005;41:652-6.
121. Pillny M, Sandmann W, Luther B, Muller BT, Tutschek B, Gerhart A, et al. Deep vein thrombosis during pregnancy and after delivery: indications for and results of thrombectomy. J Vasc Surg 2003;37:528-32.